Filing Details

Accession Number:
0001209191-23-054968
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-13 16:01:53
Reporting Period:
2023-11-09
Accepted Time:
2023-11-13 16:01:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434316 Fate Therapeutics Inc FATE Biological Products, (No Disgnostic Substances) (2836) 651311552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1655472 Cindy Tahl C/O Fate Therapeutics, Inc.
12278 Scripps Summit Drive
San Diego CA 92131
General Counsel And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-09 24,363 $2.40 153,235 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.